Blog
ToolGen Files Complaint Against Vertex Concerning Gene Therapy Casgevy®
On November 18, 2025, ToolGen, Inc. (“ToolGen”) filed a complaint (“Complaint”) in the District of Massachusetts alleging infringement of its U.S. Patent No. 12,473,559 (“the ’559 patent”) by Vertex Pharmaceuticals and related entities involved in the development and manufacture of the gene-edited therapy Casgevy® (exagamglogene autotemcel)….
By: Venable LLP